Daan Van Well

Executive

Directeur Juridique

Insider activity · 24 months0 buys9 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 1 saleApr 26 · 0 buys · 6 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 1 sale

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (9 ops.)

€142k

Latest filing published 07 Oct 2026 for SOPHiA GENETICS SA, €45k. Read the official filing

Filing timeline

BuySale

Daan Van Well

Insider track record

Disclosed buys

Disclosed sells

Signal history

Daan Van Well: trading record in brief

Daan Van Well, listed as senior executive, appears in our data through filings on SOPHiA GENETICS SA shares, published by SEC (Form 4). Between 19 March 2026 and 5 October 2026, the trades on record add up to 11 filings.

No open-market purchase appears, only 9 sales worth €142k. Besides market trades, the filings include 2 share grants.

Most recently, on 7 October 2026, the filings show an open-market sale worth €45k in SOPHiA GENETICS SA. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.